The DOI matches its Crossref record.
Platelet-Leukocyte Cross Talk in Whole Blood
Open accessAbstract
Abstract —Thrombosis and inflammation involve complex platelet-leukocyte interaction, the details of which are not fully elucidated. Therefore, we investigated cross talk between platelets and leukocytes in whole blood, under the following physiological conditions: at 37°C, with normal calcium concentrations, and with shear force. Platelet P-selectin and leukocyte CD11b expression were used to monitor platelet and leukocyte activation, respectively, and platelet-leukocyte aggregation (PLA) was analyzed. The leukocyte-specific agonist N -formyl-methionyl-leucyl-phenylalanine (10 −6 mol/L) increased P-selectin–positive platelets from 2.5±0.1% to 5.1±0.6% ( P <0.05). The increase was inhibited by either the platelet-activating factor (PAF) antagonist SR27417, the superoxide anion scavenger superoxide dismutase, the 5-lipoxygenase inhibitor Zileuton, or the 5-lipoxygenase–activating protein inhibitor MK-886, suggesting the involvement of PAF, superoxide anion, and 5-lipoxygenase products in leukocyte-induced platelet activation. The platelet-specific agonist collagen (1 μg/mL) increased leukocyte CD11b expression from 2.94±0.52 to 3.81±0.58 ( P <0.05); this was not inhibited by the thromboxane A 2 receptor antagonist ICI 192.605 or the PAF antagonist SR27417. Platelet P-selectin expression induced by N -formyl-methionyl-leucyl-phenylalanine and leukocyte CD11b expression induced by collagen could be suppressed by glycoprotein IIb/IIIa blockade or P-selectin blockade. This study documents platelet-leukocyte cross talk under conditions that mimic a physiological state and suggests that this involves multiple mediators and mechanisms. Furthermore, new evidence of integrin and selectin involvement in intracellular and intercellular signaling during platelet-leukocyte cross talk is provided.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms
Stirban, A., Gawlowski, T., & Roden, M. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2013.11.006 · Cited by 361
The role of platelets in immune-mediated inflammatory diseases
Scherlinger, M., Richez, C., Tsokos, G. C., Boilard, E., & Blanco, P. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00834-4 · Cited by 346
Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum
Vieira-de-Abreu, A., Campbell, R. A., Weyrich, A. S., & Zimmerman, G. A. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0286-4 · Cited by 321
Wahrenbrock, M., Borsig, L., Le, D., Varki, N., & Varki, A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318882 · Cited by 317
Platelet chemokines and chemokine receptors, linking hemostasis, inflammation, and host defense
GEAR, A. R. L., & CAMERINI, D. (2003) · Microcirculation · doi:10.1038/sj.mn.7800198 · Cited by 317
“Important platelet interactions with different leukocytes such as monocytes and neutrophils also are involved (23,39, 43,46,92,122).”
Background
Metadata
- Authors
- Li, N., Hu, H., Lindqvist, M., Wikström-Jonsson, E., Goodall, A. H., & Hjemdahl, P.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2000-12
- Volume
- 20
- Issue
- 12
- Pages
- 2702-2708
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2128642633
- Cited by
- 199
- References
- 0
- FWCI
- 4.54
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Platelet-Leukocyte Cross Talk in Whole Blood. https://app.cochat.ai/papers/10.1161/01.atv.20.12.2702
- The paper
- Li, N., Hu, H., Lindqvist, M., Wikström-Jonsson, E., Goodall, A. H., & Hjemdahl, P. (2000). Platelet-Leukocyte Cross Talk in Whole Blood. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/01.atv.20.12.2702
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.